PERGAM; Tania

Patent Applications and Registrations

Patent applications and USPTO patent grants for PERGAM; Tania.The latest application filed is for "c10rf32 antibodies, and uses thereof for treatment of cancer".

Company Profile

1.7.13

PERGAM; Tania - Richon LeZion IL
PERGAM; Tania - Rishon LeZiyyon IL
PERGAM; Tania - Rishon LeZion IL
Pergam; Tania - Rishon Le Zion IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
C10rf32 Antibodies, And Uses Thereof For Treatment Of Cancer App 20200002416 - COJOCARU; Gady S. ; et al.	2020-01-02
Polypeptides And Polynucleotides, And Uses Thereof As A Drug Target For Producing Drugs And Biologics App 20180298109 - COHEN-DAYAG; Anat ; et al.	2018-10-18
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics Grant 10,098,934 - Levine , et al. October 16, 2	2018-10-16
C10rf32 Antibodies, And Uses Thereof For Treatment Of Cancer App 20170233473 - COJOCARU; Gady S. ; et al.	2017-08-17
C10RF32 antibodies, and uses thereof for treatment of cancer Grant 9,617,336 - Cojocaru , et al. April 11, 2	2017-04-11
Polypeptides And Polynucleotides, And Uses Thereof As A Drug Target For Producing Drugs And Biologics App 20170037141 - COHEN-DAYAG; Anat ; et al.	2017-02-09
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics Grant 9,555,087 - Toporik , et al. January 31, 2	2017-01-31
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics Grant 9,375,466 - Cohen-Dayag , et al. June 28, 2	2016-06-28
Biomarkers For The Prediction Of Renal Injury App 20160177395 - Kinar; Yaron ; et al.	2016-06-23
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics Grant 9,107,862 - Toporik , et al. August 18, 2	2015-08-18
C10rf32 Antibodies, And Uses Thereof For Treatment Of Cancer App 20150158947 - Cojocaru; Gady S. ; et al.	2015-06-11
Polypeptides And Polynucleotides, And Uses Thereof As A Drug Target For Producing Drugs And Biologics App 20140363446 - TOPORIK; Amir ; et al.	2014-12-11
Polypeptides And Polynucleotides, And Uses Thereof As A Drug Target For Producing Drugs And Biologics App 20140255389 - COHEN-DAYAG; Anat ; et al.	2014-09-11
Polypeptides And Polynucleotides, And Uses Thereof As A Drug Target For Producing Drugs And Biologics App 20140255411 - LEVINE; Zurit ; et al.	2014-09-11
Polypeptides And Polynucleotides, And Uses Thereof As A Drug Target For Producing Drugs And Biologics App 20140220011 - TOPORIK; Amir ; et al.	2014-08-07
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics Grant 8,415,455 - Levine , et al. April 9, 2	2013-04-09
Polypeptides And Polynucleotides, And Uses Thereof As A Drug Target For Producing Drugs And Biologics App 20120134997 - Levine; Zurit ; et al.	2012-05-31
Biomarkers For The Prediction Of Renal Injury App 20110003708 - Kinar; Yaron ; et al.	2011-01-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.